Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 293

1.

Establishing support groups to support parents of preterm babies with retinopathy of prematurity: A pilot study.

Malladi BVS, Iyer GK, Murthy GVS, Gilbert C, Shukla R, Gudlavalleti AG, Yamarthi P, Mukpalkar S.

Indian J Ophthalmol. 2020 Feb;68(Supplement):S128-S130. doi: 10.4103/ijo.IJO_1818_19.

PMID:
31937748
2.

177Lu-NM600 targeted radionuclide therapy extends survival in syngeneic murine models of triple-negative breast cancer.

Hernandez R, Grudzinski JJ, Aluicio-Sarduy E, Massey CF, Pinchuk AN, Bitton AN, Patel R, Zhang R, Kumar AV, Iyer G, Engle JW, Weichert JP.

J Nucl Med. 2019 Dec 20. pii: jnumed.119.236265. doi: 10.2967/jnumed.119.236265. [Epub ahead of print]

PMID:
31862799
3.

Activity of M3814, an Oral DNA-PK Inhibitor, In Combination with Topoisomerase II Inhibitors in Ovarian Cancer Models.

Wise HC, Iyer GV, Moore K, Temkin SM, Gordon S, Aghajanian C, Grisham RN.

Sci Rep. 2019 Dec 11;9(1):18882. doi: 10.1038/s41598-019-54796-6.

4.

Standardising Dementia Diagnosis Across Linguistic and Educational Diversity: Study Design of the Indian Council of Medical Research-Neurocognitive Tool Box (ICMR-NCTB).

Iyer GK, Paplikar A, Alladi S, Dutt A, Sharma M, Mekala S, Kaul S, Saroja AO, Divyaraj G, Ellajosyula R, Ghosh A, Hooda R, Justus S, Kandukuri R, Khan AB, Mathew R, Mathuranath PS, Menon R, Nandi R, Narayanan J, Nehra A, Padma MV, Pauranik A, Ramakrishnan S, Sabnis P, Sarath L, Shah U, Tripathi M, Sylaja PN, Varma RP, Verma M, Varghese F; ICMR Neurocognitive Tool Box Consortium.

J Int Neuropsychol Soc. 2019 Dec 12:1-15. doi: 10.1017/S1355617719001127. [Epub ahead of print]

PMID:
31826780
5.

Cancer Susceptibility Mutations in Patients With Urothelial Malignancies.

Carlo MI, Ravichandran V, Srinavasan P, Bandlamudi C, Kemel Y, Ceyhan-Birsoy O, Mukherjee S, Mandelker D, Chaim J, Knezevic A, Rana S, Fnu Z, Breen K, Arnold AG, Khurram A, Tkachuk K, Cipolla CK, Regazzi A, Hakimi AA, Al-Ahmadie H, Dalbagni G, Cadoo KA, Walsh MF, Teo MY, Funt SA, Coleman JA, Bochner BH, Iyer G, Solit DB, Stadler ZK, Zhang L, Rosenberg JE, Taylor BS, Robson ME, Berger MF, Vijai J, Bajorin DF, Offit K.

J Clin Oncol. 2019 Dec 3:JCO1901395. doi: 10.1200/JCO.19.01395. [Epub ahead of print]

PMID:
31794323
6.

Environmental co-benefits and adverse side-effects of alternative power sector decarbonization strategies.

Luderer G, Pehl M, Arvesen A, Gibon T, Bodirsky BL, de Boer HS, Fricko O, Hejazi M, Humpenöder F, Iyer G, Mima S, Mouratiadou I, Pietzcker RC, Popp A, van den Berg M, van Vuuren D, Hertwich EG.

Nat Commun. 2019 Nov 19;10(1):5229. doi: 10.1038/s41467-019-13067-8.

7.

Design and Outcomes of a Novel Keratoprosthesis: Addressing Unmet Needs in End-Stage Cicatricial Corneal Blindness.

Bakshi SK, Graney J, Paschalis EI, Agarwal S, Basu S, Iyer G, Liu C, Srinivasan B, Chodosh J.

Cornea. 2019 Nov 8. doi: 10.1097/ICO.0000000000002207. [Epub ahead of print]

PMID:
31724985
8.

Quantifying operational lifetimes for coal power plants under the Paris goals.

Cui RY, Hultman N, Edwards MR, He L, Sen A, Surana K, McJeon H, Iyer G, Patel P, Yu S, Nace T, Shearer C.

Nat Commun. 2019 Oct 18;10(1):4759. doi: 10.1038/s41467-019-12618-3.

9.

A novel endothelial damage inhibitor for the treatment of vascular conduits in coronary artery bypass grafting: protocol and rationale for the European, multicentre, prospective, observational DuraGraft registry.

Caliskan E, Sandner S, Misfeld M, Aramendi J, Salzberg SP, Choi YH, Satishchandran V, Iyer G, Perrault LP, Böning A, Emmert MY.

J Cardiothorac Surg. 2019 Oct 15;14(1):174. doi: 10.1186/s13019-019-1010-z.

10.

The landscape of immunotherapy in metastatic urothelial carcinoma.

Teo MY, Iyer G.

Curr Opin Urol. 2019 Nov;29(6):643-648. doi: 10.1097/MOU.0000000000000676.

PMID:
31567441
11.

Clinical Outcome of Autologous Cultivated Oral Mucosal Epithelial Transplantation in Ocular Surface Reconstruction.

Gopakumar V, Agarwal S, Srinivasan B, Krishnakumar S, Krishnan UM, Iyer G.

Cornea. 2019 Oct;38(10):1273-1279. doi: 10.1097/ICO.0000000000002082.

PMID:
31356413
12.

PD-L1 Expression in Urothelial Carcinoma With Predominant or Pure Variant Histology: Concordance Among 3 Commonly Used and Commercially Available Antibodies.

Reis H, Serrette R, Posada J, Lu V, Chen YB, Gopalan A, Fine SW, Tickoo SK, Sirintrapun SJ, Iyer G, Funt SA, Teo MY, Rosenberg JE, Bajorin DF, Dalbagni G, Bochner BH, Solit DB, Reuter VE, Al-Ahmadie HA.

Am J Surg Pathol. 2019 Jul;43(7):920-927. doi: 10.1097/PAS.0000000000001264.

PMID:
31135485
13.

Fendiline Enhances the Cytotoxic Effects of Therapeutic Agents on PDAC Cells by Inhibiting Tumor-Promoting Signaling Events: A Potential Strategy to Combat PDAC.

Alhothali M, Mathew M, Iyer G, Lawrence HR, Yang S, Chellappan S, Padmanabhan J.

Int J Mol Sci. 2019 May 16;20(10). pii: E2423. doi: 10.3390/ijms20102423.

14.

Defining Reprogramming Checkpoints from Single-Cell Analyses of Induced Pluripotency.

Tran KA, Pietrzak SJ, Zaidan NZ, Siahpirani AF, McCalla SG, Zhou AS, Iyer G, Roy S, Sridharan R.

Cell Rep. 2019 May 7;27(6):1726-1741.e5. doi: 10.1016/j.celrep.2019.04.056.

15.

Pembrolizumab in the treatment of locally advanced or metastatic urothelial carcinoma: clinical trial evidence and experience.

Crist M, Iyer G, Hsu M, Huang WC, Balar AV.

Ther Adv Urol. 2019 Apr 4;11:1756287219839285. doi: 10.1177/1756287219839285. eCollection 2019 Jan-Dec. Review.

16.

Altered retinoid metabolism gene expression in chronic Stevens-Johnson syndrome.

Srividya G, Angayarkanni N, Iyer G, Srinivasan B, Agarwal S.

Br J Ophthalmol. 2019 Aug;103(8):1015-1023. doi: 10.1136/bjophthalmol-2018-312849. Epub 2019 Apr 25.

PMID:
31023710
17.

MRE11 as a Predictive Biomarker of Outcome After Radiation Therapy in Bladder Cancer.

Walker AK, Karaszi K, Valentine H, Strauss VY, Choudhury A, McGill S, Wen K, Brown MD, Ramani V, Bhattarai S, Teo MTW, Yang L, Myers KA, Deshmukh N, Denley H, Browning L, Love SB, Iyer G, Clarke NW, Hall E, Huddart R, James ND, Hoskin PJ, West CML, Kiltie AE.

Int J Radiat Oncol Biol Phys. 2019 Jul 15;104(4):809-818. doi: 10.1016/j.ijrobp.2019.03.015. Epub 2019 Mar 15.

18.

Genomic landscape of inverted urothelial papilloma and urothelial papilloma of the bladder.

Isharwal S, Hu W, Sarungbam J, Chen YB, Gopalan A, Fine SW, Tickoo SK, Sirintrapun SJ, Jadallah S, Loo FL, Pietzak EJ, Cha EK, Bochner BH, Berger MF, Iyer G, Solit DB, Reuter VE, Al-Ahmadie H.

J Pathol. 2019 Jul;248(3):260-265. doi: 10.1002/path.5261. Epub 2019 Apr 22.

PMID:
30838648
19.

Author Correction: HER kinase inhibition in patients with HER2- and HER3-mutant cancers.

Hyman DM, Piha-Paul SA, Won H, Rodon J, Saura C, Shapiro GI, Juric D, Quinn DI, Moreno V, Doger B, Mayer IA, Boni V, Calvo E, Loi S, Lockhart AC, Erinjeri JP, Scaltriti M, Ulaner GA, Patel J, Tang J, Beer H, Selcuklu SD, Hanrahan AJ, Bouvier N, Melcer M, Murali R, Schram AM, Smyth LM, Jhaveri K, Li BT, Drilon A, Harding JJ, Iyer G, Taylor BS, Berger MF, Cutler RE Jr, Xu F, Butturini A, Eli LD, Mann G, Farrell C, Lalani AS, Bryce RP, Arteaga CL, Meric-Bernstam F, Baselga J, Solit DB.

Nature. 2019 Feb;566(7745):E11-E12. doi: 10.1038/s41586-019-0974-0.

PMID:
30755741
20.

Algorithmic approach to management of acute ocular chemical injuries-I's and E's of Management.

Iyer G, Srinivasan B, Agarwal S.

Ocul Surf. 2019 Apr;17(2):179-185. doi: 10.1016/j.jtos.2019.02.002. Epub 2019 Feb 8. Review.

PMID:
30742992
21.

Tumor mutational load predicts survival after immunotherapy across multiple cancer types.

Samstein RM, Lee CH, Shoushtari AN, Hellmann MD, Shen R, Janjigian YY, Barron DA, Zehir A, Jordan EJ, Omuro A, Kaley TJ, Kendall SM, Motzer RJ, Hakimi AA, Voss MH, Russo P, Rosenberg J, Iyer G, Bochner BH, Bajorin DF, Al-Ahmadie HA, Chaft JE, Rudin CM, Riely GJ, Baxi S, Ho AL, Wong RJ, Pfister DG, Wolchok JD, Barker CA, Gutin PH, Brennan CW, Tabar V, Mellinghoff IK, DeAngelis LM, Ariyan CE, Lee N, Tap WD, Gounder MM, D'Angelo SP, Saltz L, Stadler ZK, Scher HI, Baselga J, Razavi P, Klebanoff CA, Yaeger R, Segal NH, Ku GY, DeMatteo RP, Ladanyi M, Rizvi NA, Berger MF, Riaz N, Solit DB, Chan TA, Morris LGT.

Nat Genet. 2019 Feb;51(2):202-206. doi: 10.1038/s41588-018-0312-8. Epub 2019 Jan 14.

PMID:
30643254
22.

Updates on the Genetics and Molecular Subtypes of Urothelial Carcinoma and Select Variants.

Al-Ahmadie H, Iyer G.

Surg Pathol Clin. 2018 Dec;11(4):713-723. doi: 10.1016/j.path.2018.07.011. Epub 2018 Oct 17. Review.

23.

Clonal Relatedness and Mutational Differences between Upper Tract and Bladder Urothelial Carcinoma.

Audenet F, Isharwal S, Cha EK, Donoghue MTA, Drill EN, Ostrovnaya I, Pietzak EJ, Sfakianos JP, Bagrodia A, Murugan P, Dalbagni G, Donahue TF, Rosenberg JE, Bajorin DF, Arcila ME, Hechtman JF, Berger MF, Taylor BS, Al-Ahmadie H, Iyer G, Bochner BH, Coleman JA, Solit DB.

Clin Cancer Res. 2019 Feb 1;25(3):967-976. doi: 10.1158/1078-0432.CCR-18-2039. Epub 2018 Oct 23.

PMID:
30352907
24.

Genomic Differences Between "Primary" and "Secondary" Muscle-invasive Bladder Cancer as a Basis for Disparate Outcomes to Cisplatin-based Neoadjuvant Chemotherapy.

Pietzak EJ, Zabor EC, Bagrodia A, Armenia J, Hu W, Zehir A, Funt S, Audenet F, Barron D, Maamouri N, Li Q, Teo MY, Arcila ME, Berger MF, Schultz N, Dalbagni G, Herr HW, Bajorin DF, Rosenberg JE, Al-Ahmadie H, Bochner BH, Solit DB, Iyer G.

Eur Urol. 2019 Feb;75(2):231-239. doi: 10.1016/j.eururo.2018.09.002. Epub 2018 Oct 2.

PMID:
30290956
25.

Durable response to anti-PD-1 immunotherapy in epithelioid angiomyolipoma: a report on the successful treatment of a rare malignancy.

Lattanzi M, Deng FM, Chiriboga LA, Femia AN, Meehan SA, Iyer G, Voss MH, Sundatova Y, Huang WC, Balar AV.

J Immunother Cancer. 2018 Oct 1;6(1):97. doi: 10.1186/s40425-018-0415-x.

26.

Low-Grade Serous Ovarian Cancer: Current Treatment Paradigms and Future Directions.

Grisham RN, Iyer G.

Curr Treat Options Oncol. 2018 Sep 18;19(11):54. doi: 10.1007/s11864-018-0571-8. Review.

PMID:
30225651
27.

Clinical profile, risk factors and outcome of medical, surgical and adjunct interventions in patients with Pythium insidiosum keratitis.

Agarwal S, Iyer G, Srinivasan B, Benurwar S, Agarwal M, Narayanan N, Lakshmipathy M, Radhika N, Rajagopal R, Krishnakumar S, K LT.

Br J Ophthalmol. 2019 Mar;103(3):296-300. doi: 10.1136/bjophthalmol-2017-311804. Epub 2018 Sep 11.

PMID:
30206158
28.

When there is no tooth - Looking beyond the Falcinelli MOOKP.

Avadhanam VS, Zarei-Ghanavati M, Bardan AS, Iyer G, Srinivasan B, Agarwal S, Goweida M, Fukuda M, Hille K, Chodosh J, Liu CS.

Ocul Surf. 2019 Jan;17(1):4-8. doi: 10.1016/j.jtos.2018.08.006. Epub 2018 Aug 28. No abstract available.

PMID:
30170034
29.

Boston Type 2 keratoprosthesis- mid term outcomes from a tertiary eye care centre in India.

Iyer G, Srinivasan B, Agarwal S, Ravindran R, Rishi E, Rishi P, Krishnamoorthy S.

Ocul Surf. 2019 Jan;17(1):50-54. doi: 10.1016/j.jtos.2018.08.003. Epub 2018 Aug 26.

PMID:
30157458
30.

Models and Approaches Describing the Metabolism, Transport, and Toxicity of Drugs Administered by the Ocular Route.

Dumouchel JL, Chemuturi N, Milton MN, Camenisch G, Chastain J, Walles M, Sasseville V, Gunduz M, Iyer GR, Argikar UA.

Drug Metab Dispos. 2018 Nov;46(11):1670-1683. doi: 10.1124/dmd.118.082974. Epub 2018 Aug 15. Review.

PMID:
30111625
31.

Enhanced Radiosensitivity in Solid Tumors using a Tumor-selective Alkyl Phospholipid Ether Analog.

Elsaid MY, Shahi A, Wang AR, Baiu DC, Li C, Werner LR, Singhal S, Hall LT, Weichert JP, Armstrong EA, Bednarz BP, Harari PM, Iyer G, Otto M.

Mol Cancer Ther. 2018 Nov;17(11):2320-2328. doi: 10.1158/1535-7163.MCT-17-0897. Epub 2018 Aug 14.

32.

Isolation of acid from eye drop bottles being used by patients presenting with presumed scleritis.

Iyer G, Agarwal S, Srinivasan B, Narayanasamy A.

Indian J Ophthalmol. 2018 Aug;66(8):1084-1087. doi: 10.4103/ijo.IJO_82_18.

33.

Keratoprostheses in silicone oil-filled eyes: long-term outcomes.

Iyer G, Srinivasan B, Agarwal S, Pattanaik R, Rishi E, Rishi P, Shanmugasundaram S, Natarajan V.

Br J Ophthalmol. 2019 Jun;103(6):781-788. doi: 10.1136/bjophthalmol-2018-312426. Epub 2018 Jul 18.

PMID:
30021817
34.

Novel therapies in urothelial carcinoma: a biomarker-driven approach.

Iyer G, Rosenberg JE.

Ann Oncol. 2018 Dec 1;29(12):2302-2312. doi: 10.1093/annonc/mdy254.

35.

Genome doubling shapes the evolution and prognosis of advanced cancers.

Bielski CM, Zehir A, Penson AV, Donoghue MTA, Chatila W, Armenia J, Chang MT, Schram AM, Jonsson P, Bandlamudi C, Razavi P, Iyer G, Robson ME, Stadler ZK, Schultz N, Baselga J, Solit DB, Hyman DM, Berger MF, Taylor BS.

Nat Genet. 2018 Aug;50(8):1189-1195. doi: 10.1038/s41588-018-0165-1. Epub 2018 Jul 16.

36.

Lysis-independent potentiation of immune checkpoint blockade by oncolytic virus.

Oseledchyk A, Ricca JM, Gigoux M, Ko B, Redelman-Sidi G, Walther T, Liu C, Iyer G, Merghoub T, Wolchok JD, Zamarin D.

Oncotarget. 2018 Jun 19;9(47):28702-28716. doi: 10.18632/oncotarget.25614. eCollection 2018 Jun 19.

37.

ERCC2 Helicase Domain Mutations Confer Nucleotide Excision Repair Deficiency and Drive Cisplatin Sensitivity in Muscle-Invasive Bladder Cancer.

Li Q, Damish AW, Frazier Z, Liu D, Reznichenko E, Kamburov A, Bell A, Zhao H, Jordan EJ, Gao SP, Ma J, Abbosh PH, Bellmunt J, Plimack ER, Lazaro JB, Solit DB, Bajorin D, Rosenberg JE, D'Andrea AD, Riaz N, Van Allen EM, Iyer G, Mouw KW.

Clin Cancer Res. 2019 Feb 1;25(3):977-988. doi: 10.1158/1078-0432.CCR-18-1001. Epub 2018 Jul 6.

PMID:
29980530
38.

Vernal keratoconjunctivitis in human immunodeficiency virus - The possible role of T-helper 1-T-helper 2 shift.

Agarwal S, Srinivasan B, Iyer G, Sudharshan S, Kalaivani K.

Indian J Ophthalmol. 2018 Jul;66(7):1004-1006. doi: 10.4103/ijo.IJO_76_18.

39.

Commentary on "DNA damage response and repair gene alterations are associated with improved survival in patients with platinum-treated advanced urothelial carcinoma."

Teo MY, Bambury RM, Zabor EC, Jordan E, Al-Ahmadie H, Boyd ME, Bouvier N, Mullane SA, Cha EK, Roper N, Ostrovnaya I, Hyman DM, Bochner BH, Arcila ME, Solit DB, Berger MF, Bajorin DF, Bellmunt J, Iyer G, Rosenberg JE.

Urol Oncol. 2018 Jul;36(7):345-346. doi: 10.1016/j.urolonc.2018.05.011. Epub 2018 May 30.

PMID:
29859727
40.

Reply.

Iyer G, Agarwal S, Srinivasan B.

Cornea. 2018 Aug;37(8):e39-e40. doi: 10.1097/ICO.0000000000001610. No abstract available.

PMID:
29746330
41.

Multicenter Prospective Phase II Trial of Neoadjuvant Dose-Dense Gemcitabine Plus Cisplatin in Patients With Muscle-Invasive Bladder Cancer.

Iyer G, Balar AV, Milowsky MI, Bochner BH, Dalbagni G, Donat SM, Herr HW, Huang WC, Taneja SS, Woods M, Ostrovnaya I, Al-Ahmadie H, Arcila ME, Riches JC, Meier A, Bourque C, Shady M, Won H, Rose TL, Kim WY, Kania BE, Boyd ME, Cipolla CK, Regazzi AM, Delbeau D, McCoy AS, Vargas HA, Berger MF, Solit DB, Rosenberg JE, Bajorin DF.

J Clin Oncol. 2018 Jul 1;36(19):1949-1956. doi: 10.1200/JCO.2017.75.0158. Epub 2018 May 9.

42.

Calcium-dependent phosphorylation of Plasmodium falciparum serine repeat antigen 5 triggers merozoite egress.

Iyer GR, Singh S, Kaur I, Agarwal S, Siddiqui MA, Bansal A, Kumar G, Saini E, Paul G, Mohmmed A, Chitnis CE, Malhotra P.

J Biol Chem. 2018 Jun 22;293(25):9736-9746. doi: 10.1074/jbc.RA117.001540. Epub 2018 May 1.

43.

Keratoprosthesis: Current global scenario and a broad Indian perspective.

Iyer G, Srinivasan B, Agarwal S, Talele D, Rishi E, Rishi P, Krishnamurthy S, Vijaya L, Subramanian N, Somasundaram S.

Indian J Ophthalmol. 2018 May;66(5):620-629. doi: 10.4103/ijo.IJO_22_18. Review.

44.

Post-stroke social networks, depressive symptoms, and disability in Tanzania: A prospective study.

Saadi A, Okeng'o K, Biseko MR, Shayo AF, Mmbando TN, Grundy SJ, Xu A, Parker RA, Wibecan L, Iyer G, Onesmo PM, Kapina BN, Regenhardt RW, Mateen FJ.

Int J Stroke. 2018 Oct;13(8):840-848. doi: 10.1177/1747493018772788. Epub 2018 Apr 20.

45.

Intratumoral heterogeneity of ERBB2 amplification and HER2 expression in micropapillary urothelial carcinoma.

Isharwal S, Huang H, Nanjangud G, Audenet F, Chen YB, Gopalan A, Fine SW, Tickoo SK, Lee BH, Iyer G, Chadalavada K, Rosenberg JE, Bajorin DF, Herr HW, Donat SM, Dalbagni G, Bochner BH, Solit DB, Reuter VE, Al-Ahmadie HA.

Hum Pathol. 2018 Jul;77:63-69. doi: 10.1016/j.humpath.2018.03.015. Epub 2018 Mar 27.

46.

Alterations in DNA Damage Response and Repair Genes as Potential Marker of Clinical Benefit From PD-1/PD-L1 Blockade in Advanced Urothelial Cancers.

Teo MY, Seier K, Ostrovnaya I, Regazzi AM, Kania BE, Moran MM, Cipolla CK, Bluth MJ, Chaim J, Al-Ahmadie H, Snyder A, Carlo MI, Solit DB, Berger MF, Funt S, Wolchok JD, Iyer G, Bajorin DF, Callahan MK, Rosenberg JE.

J Clin Oncol. 2018 Jun 10;36(17):1685-1694. doi: 10.1200/JCO.2017.75.7740. Epub 2018 Feb 28.

47.

Novel biomarkers in bladder cancer.

Cheng ML, Iyer G.

Urol Oncol. 2018 Mar;36(3):115-119. doi: 10.1016/j.urolonc.2018.01.009. Epub 2018 Feb 19. Review.

PMID:
29472156
48.

HER kinase inhibition in patients with HER2- and HER3-mutant cancers.

Hyman DM, Piha-Paul SA, Won H, Rodon J, Saura C, Shapiro GI, Juric D, Quinn DI, Moreno V, Doger B, Mayer IA, Boni V, Calvo E, Loi S, Lockhart AC, Erinjeri JP, Scaltriti M, Ulaner GA, Patel J, Tang J, Beer H, Selcuklu SD, Hanrahan AJ, Bouvier N, Melcer M, Murali R, Schram AM, Smyth LM, Jhaveri K, Li BT, Drilon A, Harding JJ, Iyer G, Taylor BS, Berger MF, Cutler RE Jr, Xu F, Butturini A, Eli LD, Mann G, Farrell C, Lalani AS, Bryce RP, Arteaga CL, Meric-Bernstam F, Baselga J, Solit DB.

Nature. 2018 Feb 8;554(7691):189-194. doi: 10.1038/nature25475. Epub 2018 Jan 31. Erratum in: Nature. 2019 Feb;566(7745):E11-E12.

49.

Genomic Profile of Urothelial Carcinoma of the Upper Tract from Ureteroscopic Biopsy: Feasibility and Validation Using Matched Radical Nephroureterectomy Specimens.

Bagrodia A, Audenet F, Pietzak EJ, Kim K, Murray KS, Cha EK, Sfakianos JP, Iyer G, Singla N, Arcila M, Bochner BH, Al-Ahmadie HA, Solit DB, Coleman JA.

Eur Urol Focus. 2019 May;5(3):365-368. doi: 10.1016/j.euf.2018.01.005. Epub 2018 Feb 1.

PMID:
29396293
50.

Compartmentalization of HP1 Proteins in Pluripotency Acquisition and Maintenance.

Zaidan NZ, Walker KJ, Brown JE, Schaffer LV, Scalf M, Shortreed MR, Iyer G, Smith LM, Sridharan R.

Stem Cell Reports. 2018 Feb 13;10(2):627-641. doi: 10.1016/j.stemcr.2017.12.016.

Supplemental Content

Support Center